Spyre Therapeutics, Inc. — SC 13G Filings
36 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by Spyre Therapeutics, Inc. (SYRE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Spyre Therapeutics, Inc. has filed 36 SC 13G documents with the SEC since 2015. To view all SEC filings by Spyre Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | — | 0002012383-24-003588 | Nov 8, 2024 | — |
| SC 13G | SCHEDULE 13G | 0001683168-24-007319 | Oct 23, 2024 | — |
| SC 13G | — | 0002012383-24-001245 | Oct 22, 2024 | — |
| SC 13G | SPYRE THERAPEUTICS, INC. | 0000902664-24-001536 | Feb 14, 2024 | — |
| SC 13G | SPYRE THERAPEUTICS, INC. | 0000902664-24-001596 | Feb 14, 2024 | — |
| SC 13G | — | 0000315066-24-001597 | Feb 9, 2024 | — |
| SC 13G | SC 13G | 0001193125-23-294297 | Dec 13, 2023 | — |
| SC 13G | — | 0001493152-23-043412 | Dec 1, 2023 | — |
| SC 13G | SCHEDULE 13G | 0001683168-23-008109 | Nov 14, 2023 | — |
| SC 13G | — | 0001172661-23-002651 | Jul 28, 2023 | — |
| SC 13G | — | 0000935836-23-000523 | Jul 18, 2023 | — |
| SC 13G | SC 13G | 0001104659-23-079663 | Jul 10, 2023 | — |
| SC 13G | ACQUISITION OF BENEFICIAL OWNERSHIP | 0001839882-23-017505 | Jul 3, 2023 | — |
| SC 13G | — | 0001172661-23-002388 | Jun 30, 2023 | — |
| SC 13G | — | 0000935836-23-000494 | Jun 30, 2023 | — |
| SC 13G | SC 13G | 0001104659-23-021466 | Feb 14, 2023 | — |
| SC 13G | — | 0001172661-23-001246 | Feb 14, 2023 | — |
| SC 13G | SC 13G | 0001193125-23-023699 | Feb 3, 2023 | — |
| SC 13G | — | 0001319244-22-000177 | Dec 1, 2022 | — |
| SC 13G | — | 0000834237-22-009740 | Jun 9, 2022 | — |
| SC 13G | SC 13G | 0001104659-22-021612 | Feb 14, 2022 | — |
| SC 13G | SC 13G | 0001193125-22-033917 | Feb 10, 2022 | — |
| SC 13G | — | 0000919574-21-007450 | Dec 16, 2021 | — |
| SC 13G | SC 13G | 0001628280-21-002125 | Feb 12, 2021 | — |
| SC 13G | SC 13G | 0001193125-21-035800 | Feb 10, 2021 | — |
| SC 13G | — | 0000834237-21-006814 | Feb 2, 2021 | — |
| SC 13G | SCHEDULE 13G | 0000899140-20-000490 | Oct 26, 2020 | — |
| SC 13G | SC 13G | 0001193125-20-164398 | Jun 9, 2020 | — |
| SC 13G | — | 0000215457-19-006615 | Feb 8, 2019 | — |
| SC 13G | AEGLEA BIOTHERAPEUTICS, INC. | 0000902664-18-003697 | Oct 11, 2018 | — |
| SC 13G | SCHEDULE 13G | 0001144204-18-007931 | Feb 13, 2018 | — |
| SC 13G | SC 13G | 0001144204-17-062996 | Dec 8, 2017 | — |
| SC 13G | SCHEDULE 13G | 0001571049-17-001327 | Feb 14, 2017 | — |
| SC 13G | 13G INITIAL MONTHLY FILING (AGLE) | 0000053417-16-000378 | May 9, 2016 | — |
| SC 13G | SCHEDULE 13G | 0000947871-16-001113 | Apr 18, 2016 | — |
| SC 13G | NOVARTIS BIOVENTURES LTD. SC 13G 4-6-2016 (AEGLEA BIOTHERAPEUTICS, INC) | 0001140361-16-061144 | Apr 14, 2016 | — |